The human body is a complex ecosystem, and the immune system plays a crucial role in maintaining balance. Every day, billions of cells die and are removed as part of normal tissue maintenance, a process essential for immune system equilibrium and preventing harmful reactions against healthy tissues. Researchers at VIB and Ghent University have made a groundbreaking discovery: a protein known for sensing cellular stress also acts as a cholesterol sensor in specialized immune cells. This finding reveals how these cells safely process dying cells and maintain immune homeostasis.
The study focuses on conventional type 1 dendritic cells, or cDC1s, which constantly engulf dying cells throughout the body. This process is vital for maintaining immune tolerance and allowing the immune system to monitor tissues for disease signs. However, it comes with a challenge: each engulfed cell delivers a substantial amount of lipids, including cholesterol, which dendritic cells must manage carefully to function properly.
The researchers identified the protein IRE1 as a crucial regulator in this process. IRE1 is typically known as a cellular stress sensor, helping cells respond to protein misfolding in the endoplasmic reticulum. Surprisingly, the VIB team found that IRE1 performs a different role in dendritic cells.
Prof. Sophie Janssens, senior author of the study, explains, "IRE1 is activated when dendritic cells engulf dying cells and take up large amounts of cholesterol. Instead of responding to classical cellular stress, IRE1 acts as a sensor that helps these immune cells adapt to the metabolic consequences of processing dying cells."
The study revealed that without IRE1, cholesterol accumulates inside the cells, negatively affecting their survival and immune functions. IRE1 helps dendritic cells cope with the large amounts of cholesterol they take in from dying cells by activating a molecular pathway that allows cells to remove excess cholesterol. This pathway prevents cholesterol from building up to harmful levels, enabling dendritic cells to function normally.
The researchers also found that IRE1-lacking cells can be rescued by boosting cholesterol removal with reconstituted HDL particles, highlighting the importance of cholesterol balance for healthy immune function. Dendritic cells are crucial in presenting antigens to T cells and shaping immune responses. The study showed that mice lacking IRE1 in dendritic cells were less efficient at activating T cells using material derived from dying cells.
Dr. Victor Bosteels, first author of the study, states, "Our findings place IRE1 at the center of how dendritic cells sense and process dying cells. The study uncovers an unexpected connection between cholesterol metabolism and immune tolerance, adding a new layer to our understanding of how the immune system maintains balance."
This research has significant implications for understanding inflammatory diseases, autoimmunity, and immune regulation. It also provides new perspectives on how immune cells integrate metabolic and immunological signals, offering valuable insights into the complex world of the human immune system.
